ReleaseWire

Global Markets Direct's, 'Pharmicell Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Pharmicell Co., Ltd.'s pharmaceutical research and development focus.

About Therapeutic Vaccines A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

GlobalData's clinical trial report, "Polyneuropathies Global Clinical Trials Review, H2, 2014" provides data on the Polyneuropathies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polyneuropathies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polyneuropathies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2014" provides data on the Seasonal Affective Disorder (SAD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seasonal Affective Disorder (SAD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Seasonal Affective Disorder (SAD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2014', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Global Markets Direct's, 'Sirnaomics, Inc. - Product Pipeline Review - 2014', provides an overview of the Sirnaomics, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Nippon Kayaku Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Nippon Kayaku Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2014', provides an overview of the B-Cell Non-Hodgkin Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'Nanotherapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Nanotherapeutics, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Ajinomoto Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Ajinomoto Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2014', provides an overview of the Valeant Pharmaceuticals International, Inc.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2014" provides data on the Peripheral Neuropathic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Neuropathic Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Neuropathic Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Multiple Sclerosis (RMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsing Multiple Sclerosis (RMS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsing Multiple Sclerosis (RMS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Global Markets Direct's, 'Drug Addiction - Pipeline Review, H2 2014', provides an overview of the Drug Addiction's therapeutic pipeline.

Global Markets Direct's, 'Patrys Limited - Product Pipeline Review - 2014', provides an overview of the Patrys Limited's pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Global Markets Direct's, 'Ensemble Discovery Corporation - Product Pipeline Review - 2014', provides an overview of the Ensemble Discovery Corporation's pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.